D. Puthier et al., Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule, BR J HAEM, 112(2), 2001, pp. 358-363
We have recently reported that Mcl-1, an anti-apoptotic member of the Bcl-2
family, is upregulated by interleukin (IL)-6 in human myeloma cells throug
h the janus kinase/signal transducers and activators of transduction (JAK/S
TAT) pathway. In the current study, we have explored the effects of interfe
ron (IFN)-alpha, a cytokine which has been shown to increase myeloma cell s
urvival. Our results demonstrate that IFN-alpha potently upregulates Mcl-1
on both myeloma cell lines and purified native myeloma cells. Of note, this
upregulation is not due to an induction of an IL-6 autocrine loop. Further
more, we showed that IL-6 and IFN-alpha had no additive effect on Mcl-1 upr
egulation, suggesting that both cytokines act through a common mechanism. F
inally, the analysis of signalling transduction pathways strongly suggests
that Mcl-1 upregulation induced by IFN-alpha depends on STAT3 activation. A
ltogether, our data show that IFN-alpha has an IL-6-like effect on human my
eloma cells and suggest that it could be deleterious in some patients.